In this episode, Dr. Haider Warraich, Program Manager, Scalable Solutions at Advanced Research Projects Agency for Health (ARPA-H), explains why building trust, not just advancing technology, is key to unlocking the next generation of healthcare AI. Leading ARPA-H’s ADVOCATE program, he shares how the agency is accelerating the development of patient-facing, agentic AI designed to improve outcomes for people living with heart failure, while simultaneously building the regulatory and evaluation infrastructure needed to safely bring these innovations into clinical practice.

Dr. Warraich argues that healthcare must innovate and evaluate AI in parallel. As AI development accelerates, lasting trust will depend on rigorous clinical evidence, familiar regulatory pathways, and real-time post-market monitoring. He also encourages innovators to think boldly, noting that breakthrough ideas often seem unrealistic before they become reality.

Dr. Warraich sees AI alignment, patient-centered technologies for high-need populations, and high-fidelity healthcare simulations as the next frontiers of innovation. He envisions that the future of healthcare AI will be shaped by bold ideas grounded in scientific rigor, transparent evaluation, and close collaboration between innovators, regulators, and health systems. That’s how the industry will build the trust needed to scale AI and improve patient care. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS.

In this episode, Dr. Anne Snowdon, Scientific Director and CEO at SCAN Health and Chief Scientific Research Officer at HIMSS, explores why AI has the potential to transform healthcare, but only if health systems build the evidence, infrastructure, and workforce readiness to support it. She argues that while AI is generating tremendous excitement, most health systems are still in the early stages of adoption with many initiatives remaining in pilot phases.

Dr. Snowdon explains that healthcare must shift from deterministic decision-making toward probabilistic, predictive care, while developing new approaches to continuously evaluate AI as it learns and evolves. She also highlights the need to improve AI literacy among clinicians and establish stronger evidence before scaling enterprise-wide deployments.

Beyond clinical workflows, Dr. Snowdon makes a compelling case for reimagining digital health around patients rather than health systems. She envisions AI empowering individuals to better manage their health while seamlessly connecting them with trusted providers through interoperable, data-driven ecosystems. She also identifies digitally enabled supply chains as a critical but often overlooked foundation for safer, more personalized, and higher-quality care. She believes that the future of healthcare depends not just on adopting AI, but on creating connected, evidence-based systems that improve outcomes for patients, clinicians, and the broader health ecosystem. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS AI in Healthcare Forum.

In this episode, Naomi Fried, PhD, Founder and CEO of PharmStars, shares how stronger collaboration between startups and pharmaceutical companies is accelerating healthcare innovation. Drawing on leadership roles at Biogen, Kaiser Permanente, Boston Children’s Hospital, consulting work with large pharma companies, and collaboration across the digital health ecosystem, she explains why the most successful innovations are built around customer needs rather than technology alone.

Naomi discusses how PharmStars helps digital health startups, including those developing AI-powered solutions, understand the pharmaceutical industry, refine their value proposition, and build lasting partnerships with global pharma companies. She highlights AI as one of the most exciting areas of innovation, with the potential to improve patient care, support clinicians, and create new opportunities for life sciences organizations. However, Naomi emphasizes that technology alone is never enough. Successful innovators listen more than they pitch, understand customer pain points, and build trusted relationships.

Naomi also talks about the importance of clinician workflows, internal champions, and continuous product evolution. Whether leveraging AI, software, or medical devices, her message is clear: lasting innovation comes from solving meaningful problems, adapting to customer needs, and building partnerships that create real-world impact. Take a listen.

In this episode, Dr. Dhruv Khullar, Associate Professor of Medicine and Population Health Sciences at Weill Cornell Medicine, explores how technology, public trust, and the evolving role of physicians are reshaping healthcare. Drawing on his experience as both a practicing clinician and a leading commentator on health policy, he argues that medicine is no longer the singular authority on health. Physicians now share influence with social media, AI tools, direct-to-consumer health companies, and a growing ecosystem of digital health platforms.

Dr. Khullar also discusses the promise and pitfalls of AI, emphasizing that while the technology can improve documentation, patient navigation, drug discovery, and clinical decision support, its adoption must be guided by evidence and rigorous evaluation. According to him, AI’s greatest opportunity may be helping restore the human connection in care by removing administrative burdens and creating more space for meaningful patient interactions.

The conversation also explores physician education, AI literacy, value-based care, public trust, and the growing commercialization of healthcare. Dr. Khullar returns to a central theme: technology alone will not solve healthcare’s challenges. Progress will require stronger communication, thoughtful leadership, and a renewed commitment to putting patients, not profit, at the center of care. Take a listen.

This guest appearance was facilitated through conversations initiated at Health Tech Summit.

In this episode, Julie Demaree, Vice President and Chief Technology and Digital Innovation Officer at St. Mary’s Healthcare, shares a pragmatic approach to digital transformation in rural healthcare, where innovation is driven by operational realities rather than technology hype. A former physician assistant turned technology executive, Julie argues that successful innovation begins with culture, governance, and clinician engagement, not new tools.

She discusses how St. Mary’s has improved patient safety and clinician experience by rethinking clinical decision support, reducing alert fatigue through careful curation, and involving frontline clinicians in governance decisions. Julie also highlights the importance of optimizing existing technology before investing in new solutions, noting that many organizations overlook capabilities already available within their EHRs.

Julie sees significant potential for automation and agentic AI to reduce administrative burden, improve patient access, and help lean teams operate more effectively. She emphasizes that AI adoption must be accompanied by strong governance, user education, and critical thinking. Her message is clear: innovation is not about adding more technology, it’s about solving the right problems, eliminating unnecessary work, and building systems that better support patients, clinicians, and communities. Take a listen.

In this episode, Marshall Glanzer, Chief Technology Officer of Town Square Health, outlines a bold model for scaling fully capitated risk programs for Medicare recipients. Transitioning from food-delivery logistics at GrubHub, Marshall brings critical structural insights for digital health innovators seeking to scale clinical models without eroding patient trust.

The core theme of the discussion centers on a counter-intuitive tech strategy: utilizing advanced digital infrastructure to intentionally deepen human relationships rather than automate them away. Town Square orchestrates unified “coordinated care visits,” bringing the patient, primary clinician, and a remote specialist into a single conversation to act as a multi-disciplinary “healthcare oracle” at the point of care.

For technology vendors, Marshall defines a safe clinical AI deployment roadmap using an “augmented clinician” framework. Advanced workflows, like chat-first patient portals managed by an automated “AI judge,” rely on the licensed physician as the ultimate orchestrator. This approach elegantly bypasses commercial barriers like malpractice liability, credentialing, and fractured billing, leveraging the financial alignment of value-based care to fully absorb modern R&D costs. Take a listen.

In this episode, Dr. Ben Long, Director of Hospital Medicine at Magnolia Regional Health Center and Weston Blakeslee, VP of Clinical Intelligence at DrFirst, break down a critical industry starting point – the reality that one in five new prescriptions is never filled and half of all refills are eventually abandoned. Sharing the results of their peer-reviewed study published in PLOS Digital Health, Dr. Long and Weston offer a grounded blueprint for how resource-constrained community health systems can conquer chronic heart failure readmissions.

The core theme of the conversation underscores an industry-wide shift from reactive, episodic care silos toward a proactive, connected population health management. While automated SMS nudges provide real-time cost transparency and essential medication education, the ultimate force multiplier lies in pairing those digital touchpoints with frontline, nursing-led care navigation. By connecting digital prescribing insights with real-world human validation, this “trust-first” design bridges the gaps between discharge and the home medicine cabinet. Take a listen.

In this episode, Omkar Kulkarni, VP, Chief Transformation & Innovation Officer at Children’s Hospital Los Angeles (CHLA), outlines the stark funding gap in pediatric innovation, which receives less than 1% of digital health investments despite children making up 20% of the population. To combat this, the CHLA-led KidsX consortium unites children’s hospitals nationwide to scale early-stage digital solutions through collaboration over competition.

Omkar suggests that pediatrics requires entirely separate technological blueprints, hence digital tools must be designed for adult caregivers, accommodate strict adolescent privacy laws at age 12, and scale across diverse physiological sizes. He highlights vital innovation pipelines, including AI tools targeting the youth mental health crisis, longitudinal chronic care management, and 24/7 validated conversational interfaces for parents.

For healthcare startups entering this space, Omkar emphasizes that the key to building institutional trust relies on presenting deep, heterogeneous clinical evidence, establishing commercially viable billing frameworks, and practicing deep humility when approaching complex clinical partnerships. He believes that generative AI will not replace clinicians but will instead automate administrative tasks, empowering them to focus on top-of-license, human-to-human care. Take a listen.

In this episode, Dr. Nele Jessel, Chief Medical Officer at athenahealth, explores the rapid shift in physician sentiment toward AI and why healthcare may finally be reaching a true inflection point in digital transformation. Dr. Jessel explains how decades of EHR-induced administrative burnout initially made clinicians wary of new technology. However, the arrival of ambient note generation changed the game almost overnight, removing immense cognitive load and restoring the intimate, face-to-face physician-patient relationship.

A core theme of the discussion is the critical pivot toward clinician-guided development rather than vendor-driven solutions. Dr. Jessel details how athenahealth uses rapid “pre-alpha” prototyping to tackle the modern challenge of interoperability data-overload, deploying large language models to synthesize complex clinical records into actionable insights at the point of care. While emphasizing that medicine remains an art that requires a human in the loop for diagnostics, she outlines a future where autonomous, agentic AI conquers administrative burdens like prior authorizations. Ultimately, healthcare is reaching a true inflection point, transforming the EHR from a passive data repository into an invisible, intelligent assistant. Take a listen.

This guest appearance was facilitated through conversations initiated at ViVE.

In this episode, Sally Ann Frank, Global Lead for Health and Life Sciences at Microsoft for Startups, discusses how AI is moving beyond experimentation toward measurable enterprise impact. She emphasizes that the most successful startups differentiate themselves not just through technology innovation, but through evolving business models, strong customer discovery practices, and a coachable mindset grounded in strategic mentorship.

Sally explores the challenge of “pilot purgatory,” noting that founders must design for production from day one. Establishing clear ROI frameworks and demonstrating early value are essential to maintaining momentum and avoiding the law of diminishing interest often seen in stalled pilots. Looking toward 2026, Sally envisions a “show me the money” era centered on four bridges: expanding global access through virtual technology to democratize care, closing the investment gap in women’s health beyond reproductive care, advancing AI-driven precision medicine through genetics for individualized treatment, and shifting healthcare from reactive treatment toward preventative longevity. Ultimately, the conversation highlights that lasting success in AI will belong to organizations that evolve into trusted advisors, consistently delivering value at every interaction. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS.

In this episode, Andrew Porter, CEO of Wayne General Hospital, shares how a community-based health system is navigating the dual pressures of financial sustainability and rural healthcare delivery. Drawing on his unique “three-legged stool” perspective as a clinician, administrator, and academic, Andrew highlights the necessity of staying nimble in a rapidly evolving market.

Wayne General is taking a pragmatic approach to AI by focusing on real problems instead of technology hype. Andrew details the successful implementation of ambient AI documentation, which has improved provider satisfaction and restored the intimacy of the patient-physician relationship. He also discusses leveraging AI partnerships to bring high-sophistication care, such as heart murmur detection, to rural populations. Andrew emphasizes the critical need for AI-driven transformation in the revenue cycle to alleviate the administrative complexity burdening small hospitals. Take a listen.

In this episode, Dr. Bharat Sutariya, Senior Vice President and Chief Health Officer at Oracle Health, discusses the radical transformation of healthcare through AI-native digital platforms. As an emergency physician with over 25 years of experience, including leadership roles at Cerner and Deloitte, Dr. Sutariya provides a unique perspective on moving past the “burden” of legacy EHR systems.

The core of the conversation centers on Oracle’s bold bet: moving away from the industry-standard “bolt-on” AI approach. Instead, Oracle is rebuilding the healthcare stack from the ground up, embedding AI into the foundational layer. Dr. Sutariya argues that the future of healthcare technology isn’t just about capturing data but about systems of orchestration. This means AI that doesn’t just transcribe a note but listens to the clinical intent to automatically queue orders, handle referrals, and initiate prior authorizations.

Dr. Sutariya predicts that within a year, the conversation will shift from documentation efficiency to a truly connected, intelligent ecosystem that gives time back to both providers and patients. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS.

In this episode, Linda Stevenson, Chief Operations & Information Officer at Fisher-Titus Health, shares how rural health systems are driving innovation under significant resource constraints. Leading a 100-bed community hospital with a lean IT team, she highlights the realities of “doing more with less”—from workforce shortages to the critical need for interoperability in coordinating care beyond organizational walls.

Linda challenges the industry’s fixation on AI as a standalone strategy, advocating instead for a problem-first approach: start with the clinical or operational need, then determine if AI is the right fit. She emphasizes that true transformation comes from aligning technology with enterprise priorities, not chasing hype.

She also points to persistent gaps in interoperability and growing cybersecurity risks, particularly in rural settings where vulnerabilities can impact the broader ecosystem. Her message is clear: stay grounded in strategy, focus on outcomes, and prioritize partnership over products to drive meaningful, scalable change. Take a listen.

This guest appearance was facilitated through conversations initiated at ViVE.

In this episode, Dr. Ruchi Garg, Chief Medical Officer at Fairview Park Hospital, shares how frontline clinicians are shaping the responsible adoption of AI in real-world care settings. Dr. Garg highlights how COVID accelerated digital adoption, from telehealth to remote patient monitoring, demonstrating that care can be both accessible and efficient when technology is thoughtfully applied.

Dr. Garg underscores that AI’s true value lies in reducing administrative burden, particularly in areas like documentation and prior authorization, where inefficiencies delay care and strain clinician-patient relationships. She notes that ambient AI is already improving accuracy and saving hours for physicians, with the next wave extending into orders, workflows, and care coordination.

However, she emphasizes that successful adoption depends on clinician involvement, intuitive design, and minimizing workflow friction. While AI may take on more clinical decision-making, questions around trust, liability, and human oversight remain central, making it critical for healthcare leaders to actively shape, not resist, this transformation. Take a listen.

This guest appearance was facilitated through conversations initiated at ViVE.

In this episode, Dr. Ed Lee, Chief Medical Officer at Nabla, shares how AI is moving beyond hype to reshape real-world care delivery. Drawing on his experience at Kaiser Permanente, he emphasizes that the true goal of technology is not efficiency alone, but restoring the human connection in healthcare.

Dr. Lee explores why change management, not the technology itself, is the hardest part of AI adoption, and why clinician involvement from day one is non-negotiable. He challenges the early narrative around time savings, arguing that the deeper ROI of ambient AI lies in reducing cognitive burden, restoring joy in medicine, and rebuilding the patient-physician relationship. He also looks ahead to the next frontier: clinical decision support, diagnosis capture, and chart summarization woven seamlessly into workflows. Dr. Lee’s closing thought is simple but powerful – done right, AI shouldn’t feel technical. It should feel human. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS.

In this episode, Dr. Roy Schoenberg, CEO of Aileen and Founder and Executive Director of Amwell, reflects on the evolution of telehealth and shares a bold vision for AI’s role in reshaping care delivery. He argues that telehealth has largely been used as a substitute channel for traditional visits, whereas its true potential lies in redistributing expertise and democratizing access to care at scale.

Dr. Schoenberg sees AI becoming the primary entry point to healthcare, guiding patient journeys through intelligent, cost-driven pathways while working in concert with, rather than replacing, clinical systems. Through his new venture, Aileen AI, Dr. Schoenberg introduces a fundamentally different approach to virtual care: building “staying power” in patients’ lives through deeply personalized, relationship-driven AI interactions, for seniors. By focusing on familiarity, trust, and daily engagement—delivered through simple interfaces like phone calls—Aileen aims to address the growing caregiving gap. Ultimately, he emphasizes that while AI adoption will evolve gradually, its role as a foundational layer in healthcare is inevitable. Take a listen.

This guest appearance was facilitated through conversations initiated at HIMSS.

In this episode, Dr. Michael Hasselberg, Chief Transformation and Digital Officer at Nebraska Medicine, makes a compelling case that sustainable digital transformation in healthcare requires more than technology, it demands the right organizational structure. By unifying IT, innovation, and strategy under a single transformation office, health systems can move from isolated pilots to enterprise-wide impact.

Drawing from his journey across telehealth, mobile apps, VR, and AI, Dr. Hasselberg emphasizes that true transformation is about redesigning systems to deliver the right care at the right time. Nebraska Medicine deploys nearly one new generative AI tool per month, automating capacity management, discharge workflows, and revenue cycle operations. He also highlights the value of real-world innovation units where new technologies are tested with live patients before system-wide deployment.

Dr. Hasselberg’s most provocative insight: the next frontier of AI readiness isn’t a new technology, it’s application rationalization. He argues that to lead in AI and innovation, health systems must simplify their tech stack. Take a listen.

In this episode, Dr. Stephen K. Klasko, former CEO of Jefferson Health, Executive in Residence at General Catalyst, Board Chair at DocGo, Teleflex, and one of healthcare’s most provocative voices, challenges the industry to rethink its fundamental assumptions and move toward a more sustainable, patient-centered future. He argues that despite years of discussion around value-based care and digital transformation, true disruption has been limited because stakeholders remain unwilling to fundamentally change existing business models.

Dr. Klasko argues that the healthcare system is broken, fragmented, expensive, and inequitable and that true disruption, like what Uber did to taxis or Amazon to retail, will demand that some players fail. He makes the case that the annual physical visit is a farce, and that continuous health narratives powered by wearables and AI companions are the future of proactive, personalized care.

On the tech-provider collaboration front, Dr. Klasko identifies – founder ego, misaligned incentives, and EHR-era skepticism as the biggest barriers. He advocates for co-developing solutions, sharing equity, and building genuine partnerships. Dr. Klasko’s message to healthcare leaders is unambiguous: stop turning things around 360 degrees and start making real, uncomfortable changes. Take a listen.

This guest appearance was facilitated through conversations initiated at Health Tech Summit by Cornell Tech.

In this episode, Dr. Eric Stecker, Co-founder and Chief Medical Officer at Insight Health, explores how autonomous AI agents are reshaping cardiovascular care and population health in the United States.

Dr. Stecker draws a critical distinction between autonomous action and autonomous decision-making, arguing that AI can deliver enormous clinical value today by acting autonomously on well-established care protocols, without waiting for fully autonomous diagnostic AI. He highlights that preventable conditions like hypertension and high cholesterol already have decades of evidence behind them; the real gap is in implementation, where AI-powered agents can identify at-risk patients, prompt appropriate prescriptions, and check in on medication adherence by reducing millions of avoidable cardiac events.

Dr. Stecker emphasizes that clinician involvement, not just advisory oversight, is essential to avoid alert fatigue, documentation overload, and signal-to-noise failures. He states that meaningful AI adoption requires building trust with both healthcare workers and patients, starting with autonomous action today while responsibly advancing toward autonomous clinical decision-making tomorrow. Take a listen.

This guest appearance was facilitated through conversations initiated at ViVE.

In this episode, Rachel Feinman, SVP of Innovation and Managing Director, TGH Ventures at Tampa General Hospital, shares how the organization is breaking out of “pilot purgatory” to turn digital innovation into measurable impact. With a clear mandate to move beyond endless experimentation, the focus is on starting with a strong thesis, partnering intentionally, and scaling quickly when results are proven.

Rachel reflects on her journey from law to healthcare, bringing a unique lens on strategy, execution, and deal-making. She highlights the balance healthcare must strike that is moving fast in operational and administrative workflows while taking a deliberate, governance-led approach to clinical innovation. This “go slow to go fast” mindset enables both safety and speed.

She also underscores the growing role of AI in improving logistics, supporting care teams, and unlocking real-time insights, while emphasizing responsible deployment. Beyond technology, the real opportunity lies in connecting fragmented care journeys and extending care beyond hospital walls to create a more seamless, patient-centered experience. Through strategic investments and a focus on outcomes, Tampa General is building an innovation model designed to scale impact, not just ideas. Take a listen.

In this episode, Aditya Bansod, CTO and Co-Founder of Luma Health, about why healthcare AI often underdelivers — and what leaders must do to turn promise into performance.

Aditya argues that AI’s challenge in healthcare isn’t ambition, but execution. While new tools are emerging rapidly, most remain point solutions that fail to integrate into the complex workflows that move patients from scheduling to care delivery. True impact, he says, depends on orchestrating the “last mile” of healthcare, referrals, intake, documentation, and the countless operational handoffs that determine whether care actually happens.

He shares how Luma approaches AI adoption with flexible guardrails, allowing health systems to calibrate automation based on confidence thresholds and maturity. The conversation also explores the rise of agentic AI, the tension between human-in-the-loop oversight and autonomy, and why CIOs are navigating a messy but necessary consolidation phase.

Looking ahead, Aditya is optimistic that AI will transform patient access and engagement, only if it’s deeply embedded into workflows, not layered on top of them. Take a listen.

In this episode, Dr. Andrea Willis, SVP and Chief Medical Officer at BlueCross BlueShield of Tennessee, shares how payers can harness AI to advance affordable, accessible, and more human-centered care.

From her clinical roots to leading population health, quality, and health equity initiatives, Dr. Willis brings a deeply personal commitment to service. She describes how AI is being deployed across care management and utilization management, not to replace clinicians or deny care, but to augment teams, accelerate evidence-based decisions, and close gaps in care. In care management, AI-powered summarization and prompting help staff stay fully present with members while improving engagement and measurable outcomes. In utilization management, transparency, evidence-based criteria, and clear documentation remain foundational to rebuilding provider trust. She also highlights that relevance matters more than data volume, and that guided self-service must balance automation with timely human escalation.

Dr. Willis emphasizes transparency in prior authorization, cross-functional governance, AI literacy goals across the enterprise, and strong PHI protections. For here, scaling AI responsibly – through interoperability, collaboration, and measurable impact – is key to rebuilding trust and transforming the healthcare experience. Take a listen.

In this episode, Dr. Amit Phull discusses what responsible AI adoption in healthcare really looks like, starting with trust, usability, and preserving clinician judgment. He emphasizes that ease of use and confidence in outputs are non-negotiable for clinician adoption, especially in already time-constrained workflows.

The discussion also explores why AI must be built with clinicians, not simply deployed for them, and how poorly integrated tools risk adding friction instead of value. Dr. Phull also talks about preserving a clinician’s “spidey sense”—the intuition developed through experience—while using AI to augment, not override, clinical judgment. The conversation also touches on how success should be measured beyond dashboards, including recurrent use, time savings, and reductions in burnout.

Dr. Phull states that AI, when designed thoughtfully, can help clinicians reclaim time, sharpen expertise, and focus more fully on patient care, without losing the human edge that defines great medicine. Take a listen.

In this episode, Dr. Chethan Sathya, Vice President of Strategic Initiatives at Northwell Health, unpacks why healthcare innovation only scales when clinicians, public health, and AI are designed to work together.

Dr. Sathya shares his journey from surgery to journalism to public health advocacy, including leading gun violence prevention efforts. He explains why most AI pilots fail, because of poor workflow integration and clinician burden, and why ambient intelligence, tele-specialty care, and agentic AI are poised to scale. His message is clear: build technology alongside clinicians, not around them. Take a listen.

In this episode, Jonathan Bush, Founder & CEO of Zus Health, shares a bold vision for the next phase of healthcare transformation. Drawing on decades of experience, Jonathan argues that while EHR adoption is largely complete, today’s systems remain fee-for-service–oriented, creating fragmented views of patients – what he describes as the “blind men and the elephant” problem. The result: clinicians still lack a complete, longitudinal picture of the patient and rely on repeated tests and “bags full of records.”

Jonathan explains how Zus Health is re-architecting healthcare data by creating a longitudinal, always-on common patient record. Zus is an API-first platform built on an AI-enabled backbone that aggregates, structures, and continuously updates data across multiple EMRs. He emphasizes the power of network effects, where shared intelligence can eliminate redundant tests and unnecessary care.

The conversation also explores why interoperability must move beyond regulatory compliance to become core infrastructure for value-based care, and how AI-driven summarization and agentic workflows can reduce clinician burden while enabling proactive, patient-centered care. Take a listen.

In this episode, Dr. Greg Goldmacher, Associate VP of Clinical Research at Merck, known as MSD outside of the United States and Canada, explains how AI is transforming imaging, clinical trials, and early-stage drug development. Greg describes endpoints as the core of every clinical trial, since they determine whether a therapy is safe or effective. He notes that AI is not new to imaging and aligns well with pattern recognition, yet its real value lies in identifying details that humans often miss.

Greg stresses that drug development still depends on huge volumes of data spread across legacy systems. Without strong data standardization, AI cannot deliver reliable results. He also points to the FDA’s evolving guidance on AI and emphasizes the need for rigorous validation before using AI-derived measurements for regulatory decisions.

Greg highlights the opportunity to improve efficiency, reduce human burden, and generate more consistent insights. With thoughtful adoption, AI can support better decisions in clinical development and improve outcomes for patients. Take a listen.

In this episode, Lisa Hunter, Senior Director of Federal Policy and Advocacy at United States of Care, discusses how her organization is working to ensure every American has access to affordable, high-quality care, with a particular focus on rural communities. She explains the new Rural Health Transformation Program—a 50-billion-dollar, five-year federal investment that gives states a rare opportunity to redesign rural health delivery, address workforce gaps, and move toward “patient first care” models that emphasize coordination, whole-person care, and sustainable payment structures.​​

Lisa highlights a growing trust gap around AI in healthcare, noting that patients are more comfortable with AI in back-office and ambient use cases compared to roles that feel like they replace clinicians. She stresses the need for rigorous listening, research, and language that resonates with people, so policy and technology decisions reflect real experiences rather than abstract concepts. Take a listen.

In this episode, Matthew Blosl, CEO of DexCare, discusses how he helps high-growth healthcare technology companies navigate critical inflection points by pairing disciplined focus with a culture that embraces failure as a path to innovation. He describes DexCare’s journey from a Providence Health incubated initiative to a scaled care orchestration platform that helps health systems address a “trilemma” of rising patient demand, clinician shortages, and margin pressure.

Matt explains DexCare’s co-innovation model, where every health system becomes an innovation partner rather than a one-size-fits-all implementation, enabled by modern data and AI capabilities. He outlines a pragmatic AI roadmap: first improving internal operations, then enhancing existing products, and finally accelerating true product innovation, while warning that AI can easily drive teams off-mission without strong focus. Matt also points out how fast things are shifting in healthcare and encourages leaders to rethink how they run their organizations and come together more often to tackle the challenges ahead. Take a listen.

In this episode, Dr. Felicia Newhouse, Founder of AI-Powered Women, highlights the need for human centered leadership as the foundation for AI’s future in healthcare. Reflecting on her near-death experience and two decades in tech, she warns that rapid automation may boost efficiency but often leaves people feeling overwhelmed, disconnected, and burned out.

Dr. Newhouse emphasizes that true progress requires qualities only humans can bring, empathy, intuition, emotional intelligence, and what she describes as “systems awareness” and “systems feeling.” These capabilities help leaders understand the broader human impact of digital tools and design AI that supports well-being rather than replacing human judgment.

She urges organizations to slow down, prioritize dignity and belonging, and adopt AI in ways that strengthen human connection. According to Dr. Newhouse, the real unlock for healthcare will come when AI is guided by compassion, humanity, and mindful leadership. Take a listen.

In this episode, Dr. Chris Gallagher, Founder and Chief Strategy Officer at Access TeleCare, shares valuable insights on the evolution of AI, how virtual care is reshaping access, staffing, and costs across health systems, and why making technology effortless is the key to driving a successful virtual-first care strategy.

Chris recounts the pioneering achievement of building the first virtual ICU in Texas in 2013, which quickly proved life-saving and marked a turning point in virtual health adoption. He discusses how they are addressing physician distribution issues by augmenting in-person staff, shifting its focus from predominantly rural to 70% urban facilities by offering essential 24/7 virtual specialists to care teams. Chris stresses that solutions must be effortless for clinicians, “Fisher Price easy,” so adoption becomes self-perpetuating.

Chris highlights AI’s immense potential to improve efficiency, enhance physician experience, and expedite patient care, especially through automation and a future “virtual-first” healthcare strategy. Take a listen.

In this episode, Charles E. Christian, VP of Technology and CTO at Franciscan Health, shares reflections from his five-decade journey in healthcare IT and how Franciscan is blending mission, compassion, and innovation to transform patient care.

Chuck explains how the health system is approaching AI adoption through strong governance and a clear focus on solving real problems, from reducing clinician burden to enhancing care delivery. He highlights several key initiatives, including voice agent pilots that help physicians reclaim after-hours time, a Tech Innovation Lab that allows teams to safely experiment and “fail fast,” and a virtual nurse mentoring program that connects senior nurses with new graduates for real-time guidance.

Chuck states that technology should serve, not distract, and the true goal of digital transformation is to enable better care for people. Take a listen.

In this episode, Anil Saldanha, Chief Innovation Officer at Rush University System for Health shares how Rush is addressing deep-rooted health inequities in Chicago by targeting the life expectancy gap through bold, system-wide interventions.

Anil highlights Rush’s commitment to public health, chronic disease management, and early cancer detection by referring to innovative initiatives like Rush Connect Plus, which is an on-demand, subscription-based virtual care model, and the rollout of Grail’s multi-cancer early detection test. He explains their use of cutting-edge AI technologies, from ambient listening and AI-powered symptom checkers to novel behavioral health kiosks leveraging multi-agent generative AI for PTSD care.

Anil points to the impact of consumer-driven digital tools, health equity analytics, and a data warehouse that will enable targeted interventions for chronic care. He closes with optimism about AI’s future in healthcare, the shift toward “connected care anywhere,” and the growing role of empowered, informed patients. Take a listen.

In this episode, Dr. Paul Yi, Associate Member, Department of Radiology, Section Chief of Intelligent Imaging Informatics (I3) at St. Jude Children’s Research Hospital, shares his journey from radiology training at Johns Hopkins to leading AI initiatives at St. Jude, focusing on pediatric cancer and other catastrophic diseases. 

Dr. Yi highlights how AI is transforming the radiology workflow, from automating imaging protocols and improving image reconstruction to translating complex medical reports into patient-friendly language. He emphasizes the importance of data strategy, discussing the integration of clinical EMRs, PACS, and research databases, ensuring interoperability while leveraging domain expertise across disciplines. He explores generative AI applications, including virtual imaging trials that simulate patient populations for safer, faster, and cost-effective clinical research, as well as patient-facing applications like AI chatbots for healthcare education, noting both potential and limitations in trust and accuracy.

Dr. Yi reflects on bridging research and commercialization, underscoring the need to align academic and industry incentives. He envisions a future powered by multimodal AI models that combine imaging, vitals, labs, and clinical text to deliver comprehensive, personalized insights – accelerating precision care and innovation in pediatric oncology. Take a listen.

In this episode, Dr. Andreas Michaelides, Clinical Psychologist helping shape Clinical AI with Google and Former Chief of Psychology at Noom, discusses the evolving intersection of technology and psychology, emphasizing how digital platforms and behavioral science can drive meaningful health outcomes at scale.

Drawing from his extensive experience at Noom and current role at Google, he highlights the value of integrating personalized care, education, and accountability through innovative technologies such as AI and wearables. Dr. Michaelides explores the ethical complexities and societal impact of AI-driven health solutions, underscoring the necessity for thoughtful governance and responsible implementation. He notes the transformative potential of predictive analytics and adaptive digital tools in enabling better assessments, interventions, and relationships between humans and technology.

Dr. Michaelides encourages practitioners to embrace uncertainty, unlearn traditional paradigms, and innovate by merging expertise with curiosity. While acknowledging fears around the rapid pace of tech advancement, he conveys an optimistic outlook on the future of digital health and behavioral change. Take a listen.

In this episode, Jan Beger, Global Head of AI Advocacy at GE Healthcare, shares his mission to bridge the gap between the conceptual promise and real-world impact of AI in healthcare. He stresses on the critical need to build AI literacy and trust among clinicians, executives, and students, and explains why a human-centric approach and strong change management are critical for successful adoption.

Jan highlights GE’s global AI literacy programs that train employees and clinicians on responsible use, practical applications, and critical evaluation of AI. He highlights how moving beyond pilots to strategic, systemwide deployment requires continuous education, executive engagement, and a focus on change management. He also spoke about GE’s successes such as improved efficiency in software development and innovations like AI-guided handheld ultrasound devices that democratize imaging by supporting users of varied expertise, as well as the challenges of keeping AI tools robust and up-to-date.

Jan addresses the future of the workforce, noting that adaptability and tech fluency will be essential as 70% of job skills evolve by 2030. He encourages healthcare leaders to see AI not just as technology, but as a transformative tool to enhance care and outcomes. Take a listen.

In this episode, Thomas Fuchs, Chief AI Officer at Eli Lilly, shares his journey from early machine learning research to spearheading transformative AI initiatives across the pharmaceutical value chain. Lilly is running over a thousand AI projects—from drug discovery and development to manufacturing and commercial operations—leveraging innovations like language models for chatbots, computer vision for quality control, and biomarker development.

Thomas emphasizes trust, transparency, and collaboration as critical to AI adoption, supported by AI certification programs for all Lilly technology employees, as well as AI education resources being made available for everyone at Lilly. He also highlights the company’s unique “lab-in-the-loop” setups that generate synthetic data to accelerate innovation.

Thomas shares real-world successes, including AI-assisted drug discovery and intelligent chatbots, and how AI is building confidence across the organization. With robust data infrastructure and scalable strategies for synthesizing large datasets, Lilly is driving rapid innovation. Thomas predicts faster drug design, broader access to medicines, and continuous education as defining trends for AI in healthcare. Take a listen.

In this episode, Dr. Girish N. Nadkarni, Chief AI Officer at Mount Sinai Health System, discusses his background as a physician-technologist and his vision for AI in healthcare as a tool that augments rather than replaces clinicians.

Dr. Nadkarni shares insights on how AI is reshaping healthcare. He describes AI as an ‘arbitrage of knowledge for time,’ enabling physicians to spend less time on administrative work and more time with patients. He also shares real-world examples including ambient AI scribes that eliminate manual note-taking and predictive models that detect patient deterioration hours before it occurs, especially in critical care units such as the NICU. Dr. Nadkarni distinguishes predictive AI’s deterministic approach from generative AI’s flexible, non-linear potential, emphasizing the need for governance, ethics, and trust in deploying both. He outlines Mount Sinai’s cross-functional framework—spanning care, operations, workforce, and research—supported by an assurance lab to monitor bias and safety.

Dr. Girish highlights current AI applications that save physicians time and enable proactive care, while predicting future developments will include multimodal integration of text, voice, images, and video to better reflect clinical decision-making processes. Take a listen.

In this episode, Dr. Michael Docktor, Co-founder and CEO at Dock Health, shares his journey from being a pediatric gastroenterologist at Boston Children’s Hospital to building a healthcare technology company. Inspired by his sister’s medical experiences and his family’s design background, Dr. Doctor combined medicine, design, and technology to address inefficiencies in operational workflows, particularly the administrative burdens that weigh heavily on providers and staff.

Dr. Docktor explains how Dock Health was created to serve as a productivity platform for healthcare, filling the gap between electronic health records (EHRs) and the countless administrative tasks not supported by them. By digitizing and streamlining processes like referrals, patient intake, and care coordination—often still managed through faxes, emails, and spreadsheets—Dock Health aims to reduce redundancy, improve visibility, and enhance the overall user experience for healthcare organizations of all sizes.

The conversation also focuses on the role of AI and automation in transforming healthcare operations. Dr. Docktor highlights Dock Health’s “AI‑first” approach, incorporating generative AI and agentic models to automate routine tasks while keeping humans in the loop for oversight. He envisions a near future where administrative inefficiencies are largely eliminated, giving clinicians more time with patients. Dr. Docktor also describes AI as the “big unlock” that could massively reduce the trillions wasted annually in healthcare administration, making care more efficient, accessible, and patient‑centered. Take a listen.

In this episode, Sameer Sethi, SVP and Chief AI & Insights Officer at Hackensack Meridian Health, shares how the health system is embedding AI directly into clinician workflows, moving from theory to real-world transformation.

Sameer outlines practical applications such as specialty-specific clinical note summarization, which reduces “pajama time” for physicians and improves patient interactions, and sentiment analysis of patient survey data, which surfaces actionable insights at scale. He also describes Hackensack’s AI governance framework – a board-approved structure with six strategic focus areas, guided by cross-departmental representation to ensure safe, effective adoption.

Emphasizing that AI solutions serve as decision-support rather than decision-making tools, Sameer highlights the importance of keeping a “human in the loop.” He sees agentic AI as the next frontier – integrating LLMs, RPA, and rule engines to automate complex processes such as prior authorizations and denial management. The result: faster workflows, administrative efficiency, and truly personalized care at scale. Take a listen.

In this episode, Ramesh Kumar, CEO and Co-founder of Zakipoint Health, shares his perspective on addressing healthcare’s persistent challenges—high costs, lack of price transparency, and fragmented care. He emphasizes that patients, or ‘members,’ often struggle to understand the true value of care, even as regulatory pushes for transparency continue.

Ramesh highlights how greater data visibility and patient empowerment can shift the system toward value-based outcomes. He emphasizes that true digital transformation goes beyond compliance and organizations must leverage transparency in data to create actionable insights for patients, employers, and providers alike. He also discusses the role of AI and agentic AI in simplifying complexity, reducing administrative burden, and enabling more personalized, efficient care delivery.

Ramesh underscores the need for co-creation between payers, providers, and technology innovators to build sustainable solutions. For him, the convergence of transparency, digital innovation, and AI marks a pivotal moment to reimagine healthcare’s future. Take a listen.